iphepha

iindaba

  Utshintsho lwe-COVID 'arcturus' entsha lubangela iimpawu ezahlukeneyo ebantwaneni

TAMPA.Abaphandi ngoku babeke esweni i-sub-variant ye-micromicron virus COVID-19 XBB.1.16, ekwaziwa njenge-arcturus.

"Izinto zibonakala ziphucuka kancinci," utshilo uGqr. Michael Teng, ugqirha wentsholongwane kunye nonjingalwazi onxulumene nezempilo yoluntu e-USF.
"Indibethe ngokwenene kuba le ntsholongwane sele mhlawumbi yeyona ntsholongwane yosulelayo eyaziwa ngumntu. Ke andiqinisekanga ukuba iya kuyeka nini le nto," utshilo uGqr. Thomas Unnash, umphandi kunye nengcali yezempilo yoluntu.
I-Arcturus inoxanduva lwe-spike yangoku kwiimeko zaseIndiya, ezibika amatyala amatsha ali-11,000 yonke imihla.
Umbutho wezeMpilo weHlabathi ubhengeze ukuba ulandelela i-subvariant kuba ngoku ifumaneka kumazwe amaninzi.Ezinye iimeko ziye zafunyanwa eUnited States.Ngokutsho kwedatha yakutshanje evela kwi-CDC, i-akhawunti malunga ne-7.2% yamatyala amatsha.

"Ndicinga ukuba siza kubona ukukhula kwaye ndicinga ukuba siza kubona into efana nale bayibona eIndiya," utshilo u-Unnash.Nangona kunjalo, bafumanisa ukuba ichaphazela abantwana abaninzi, ibangela iimpawu ezahlukileyo kwezinye iinguqulelo, kubandakanywa ukwanda kwe-conjunctivitis kunye nomkhuhlane ophezulu.

“Asikuko nokuba asizange simbone ngaphambili.Iyenzeka rhoqo,” utshilo uTen.
Amagosa ezempilo athi njengoko impuku eneempondo iqhubeka nokusasazeka, silindele ukuba abantwana abaninzi bosulelwe.
"Ndicinga ukuba enye into esiyibonayo eIndiya bubungqina bokuqala bokuba oku kunokuba sisifo sabantwana.Kulapho iintsholongwane ezininzi ziphelela khona, ”utshilo u-Unnash.
Ukhetho olusezantsi lwenzeka xa i-FDA isanda kuhlaziya isikhokelo sayo sogonyo lwe-bivalent, ibavumela kuwo onke amayeza anikwe abantu abaneenyanga ezintandathu ubudala nangaphezulu, kubandakanywa iidosi ezongezelelweyo kubantu abathile.
Izikhokelo ezitsha ziquka isincomo sokuba abantu abaneminyaka engama-65 nangaphezulu bafumane idosi yesibini yesitofu sokugonya se-bivalent kwiinyanga ezine emva kwedosi yokuqala.
I-FDA ikwacebisa ukuba uninzi lwabantu abangakhuselekanga bafumane iidosi ezongezelelweyo ubuncinci kwiinyanga ezimbini emva kwedosi yokuqala yesitofu sokugonya se-bivalent.
“Njengoko sixhalabile malunga nokuqhambuka kosulelo olunokosuleleka ngakumbi, ngoku lixesha lokuba uqale ukwakha ukhuseleko lwakho ukuze xa sibona iimeko ezininzi zolu tshintsho lutsha, uyazi ukuba amajoni akho omzimba akulungele ukulwa nawo. ,” watsho uTan.
I-SARS-CoV-2, inoveli coronavirus ngasemva kwe-COVID-19 (Umzekeliso).(ifoto ngetyala: oopopayi bezonyango/unsplash)

 


Ixesha lokuposa: Apr-24-2023